Childhood emotional and behavioral problems: Reducing overdiagnosis without risking undertreatment

Developmental Medicine and Child Neurology

Volumn 54, Issue 6, 2012, Pages 492-494

  Batstra, Laura ^a   Hadders Algra, Mijna ^b   Nieweg, Edo ^c   Van Tol, Donald ^b   Pijl, Sip Jan ^a,d   Frances, Allen ^e  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Lentis Psychiatric Institute   (Netherlands)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; CHILDHOOD DISEASE; DIAGNOSTIC ERROR; DSM-5; DSM-IV; EMOTIONAL DISORDER; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS RISK SYNDROME; REIMBURSEMENT; SELF CONCEPT; SELF ESTEEM; SPECIAL EDUCATION; TEMPER DYSREGULATION DISORDER;

BEHAVIORAL SYMPTOMS; CHILD; CHILD BEHAVIOR DISORDERS; EMOTIONS; HUMANS;

EID: 84860850882     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2011.04176.x     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention (CDC). Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder - United States 2003. MMWR Morb Mortal Wkly Rep 2005; 54: 842-7.
2. Centers for Disease Control and Prevention (CDC). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children - United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep 2010; 59: 1439-43.
3. Moreno C, Laje G, Blanco C, et al. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 2007; 64: 1032-9.
4. Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 2009; 58: 1-20.
5. Merikangas KR, Nakamura EF, Kessler RC. Epidemiology of mental disorders in children and adolescents. Dialogues Clin Neurosci 2009; 11: 7-20.
6. Conrad P. The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders. Baltimore: The Johns Hopkins University Press, 2008.
7. Swann AC, Geller B, Post RM, et al. Practical clues to early recognition of bipolar disorder: a primary care approach. Prim Care Companion J Clin Psychiatry 2005; 7: 15-21.
8. Frances A. The first draft of DSM-V. BMJ 2010; 340: c1168.
9. Verhoeff B. Drawing borders of mental disorders: An interview with David Kupfer. BioSocieties 2010; 5: 467-75.
10. Gagnon MA, Lexchin J. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med 2008; 5: e1.
11. Harris G, Carey B. Researchers fail to reveal full drug pay. New York Times 2008 (accessed 12 October 2011).
12. Frances A. Problems in defining clinical significance in epidemiological studies. Arch Gen Psychiatry 1998; 55: 119.
13. Furman L. What is attention-deficit hyperactivity disorder (ADHD)? J Child Neurol 2005; 20: 994-1002.
14. Tuin-Batstra L. Difficult Birth, Difficult Life? Ridderkerk, the Netherlands: Ridderprint Offsetdrukkerij (Dissertation University of Groningen), 2004. (in English)
15. Danforth S, Navarro V. Hyper talk: sampling the social construction of ADHD in everyday language. Anthropology & Education Quarterly 2001; 32: 167-90.
16. Harborne A, Wolpert M, Clare L. Making sense of ADHD: a battle for understanding? Parents' views of their children being diagnosed with ADHD Clin Child Psychol Psychiatry 2004; 9: 327-39.
17. Furedi F. Medicalisation in a therapy culture. In: Wainwright D, editor. A Sociology of Health. London: Sage, 2008: 97-114.
18. Broom DH, Woodward RV. Medicalisation reconsidered: toward a collaborative approach to care. Sociol Health Illn 1996; 18: 357-78.
19. Child N. Deficient attention and disordered activity: child psychiatry's response to ADHD. Clin Child Psychol Psychiatry 2003; 8: 167-78.
20. Batzle CS, Weyandt LL, Janusis GM, DeVietti TL. Potential impact of ADHD with stimulant medication label on teacher expectations. J Atten Disord 2010; 14: 157-66.
21. Jussim L. Self fulfilling prophecies: a theoretical and integrative review. Psychol Rev 1986; 93: 29-445.
22. Sayal K, Owen V, White K, Merrell C, Tymms P, Taylor E. Impact of early school-based screening and intervention programs for ADHD on children's outcomes and access to services: follow-up of a school-based trial at age 10 years. Arch Pediatr Adolesc Med 2010; 164: 462-9.
23. Tymms P, Merrell C. The impact of screening and advice on inattentive, hyperactive and impulsive children. Eur J Spec Needs Educ 2006; 21: 321-37.
24. Merton RK. Social Theory and Social Structure. New York: Free Press, 1968.
25. Ben-Zeev D, Young MA, Corrigan PW. DSM-V and the stigma of mental illness. J Ment Health 2010; 19: 318-27.
26. Walker JS, Coleman D, Lee J, Squire PN, Friesen BJ. Children's stigmatization of childhood depression and ADHD: magnitude and demographic variation in a national sample. J Am Acad Child Adolesc Psychiatry 2008; 47: 912-20.
27. Rüsch N, Corrigan PW, Todd AR, Bodenhausen GV. Implicit self-stigma in people with mental illness. J Nerv Ment Dis 2010; 198: 150-3.
28. Sparks JA, Duncan BL. The ethics and science of medicating children. Ethical Hum Psychol Psychiatry 2004; 6: 25-39.
29. Kendell RE. The Role of Diagnosis in Psychiatry. Oxford: Blackwell, 1975.
30. Zola IK. Medicine as an institute of social control. Sociol Rev 1972; 20: 487-504.
31. National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder (ADHD). September 2008. Clinical guideline 72. Available at (accessed on 14 October 2011).